BioHealth News Archive

Altimmune Announces Important Additions to its Patent Portfolio for HepTcell and ALT-702 Programs

Altimmune Announces Important Additions to its Patent Portfolio for HepTcell and ALT-702 Programs

Altimmune, Inc. (ALT), a clinical-stage biotechnology company, today announced that it has received additional patent protection for its HepTcell and ALT-702 programs in the…

Read More
Johns Hopkins announces ambitious changes to the way it prepares students for careers | Hub

Johns Hopkins announces ambitious changes to the way it prepares students for careers | Hub

Johns Hopkins University is planning a bold new approach to career development for students and alumni that includes opening three new administrative offices, launching…

Read More
Healthcare Vaccines Market studied in new Research by Focusing on Top Companies like GSK, Sanofi, Merck, Pfizer, Novartis (GSK), CSL, MedImmune LLC, J&J (Crucell), China National Biotec – Healthcare News

Healthcare Vaccines Market studied in new Research by Focusing on Top Companies like GSK, Sanofi, Merck, Pfizer, Novartis (GSK), CSL, MedImmune LLC, J&J (Crucell), China National Biotec – Healthcare News

For augmenting readability, The Research Insights has added a fresh market study, titled Vaccines Market to its flared database. The report has been put…

Read More
BIO Releases Bioscience Economic Development Guide

BIO Releases Bioscience Economic Development Guide

The Biotechnology Innovation Organization (BIO) released “Transforming Ideas into Advances: Best Practices in State and Regional Bioscience Economic Development Initiatives” today at the 2019…

Read More
2 weeks left to register! Regulatory Strategies for Emerging Healthcare/Life Science Companies: Everything You Need to Know, but Didn’t Know to Ask!

2 weeks left to register! Regulatory Strategies for Emerging Healthcare/Life Science Companies: Everything You Need to Know, but Didn’t Know to Ask!

Whether you have a medical device, diagnostic, health IT app, or therapeutic, if you have to obtain FDA approval to commercialize your product, you…

Read More
NOAA Awards $175 Million to the University of Maryland for Earth System Studies

NOAA Awards $175 Million to the University of Maryland for Earth System Studies

The National Oceanic and Atmospheric Administration (NOAA) has awarded a five-year $175 million cooperative funding agreement to the University of Maryland for collaborative research…

Read More
Emergent BioSolutions Announces FDA Approval of Change in Storage Conditions and Transfer of Manufacturing for Its Cholera Vaccine

Emergent BioSolutions Announces FDA Approval of Change in Storage Conditions and Transfer of Manufacturing for Its Cholera Vaccine

Emergent BioSolutions Inc. (EBS) today announced approval by the U.S. Food and Drug Administration (FDA) of the Prior Approval Supplement (PAS) submitted by the…

Read More
Built For Bio: Jeff Galvin, CEO & Founder of American Gene Technologies

Built For Bio: Jeff Galvin, CEO & Founder of American Gene Technologies

MCEDC discovers how Jeff is using the availability of raw talent and novel technology unique to Montgomery County, MD to help cure HIV and…

Read More
Top 50 NIH-Funded Institutions of 2019

Top 50 NIH-Funded Institutions of 2019

The great American political divide shows no sign of ending as the United States lurches toward the 2020 presidential election. However, one of the…

Read More
Emergent BioSolutions Awarded 10-Year HHS Contract Valued at Approximately $535 Million to Deliver Vaccinia Immune Globulin Intravenous (VIGIV) in Support of Smallpox Preparedness

Emergent BioSolutions Awarded 10-Year HHS Contract Valued at Approximately $535 Million to Deliver Vaccinia Immune Globulin Intravenous (VIGIV) in Support of Smallpox Preparedness

Emergent BioSolutions Inc. (NYSE: EBS) today announced a contract award by the Office of the Assistant Secretary for Preparedness and Response (ASPR) in the…

Read More
REGENXBIO Announces First FDA Approval of a Gene Therapy Based on Its Proprietary NAV® Technology Platform | REGENXBIO Inc.

REGENXBIO Announces First FDA Approval of a Gene Therapy Based on Its Proprietary NAV® Technology Platform | REGENXBIO Inc.

REGENXBIO Inc. (Nasdaq: RGNX), a leading clinical-stage biotechnology company seeking to improve lives through the curative potential of gene therapy based on its proprietary…

Read More
Gene therapy may have its first blockbuster – MIT Technology Review

Gene therapy may have its first blockbuster – MIT Technology Review

A newborn. A fatal diagnosis. And soon, a one-time gene replacement cure in the first weeks of life. The cost? You don’t want to…

Read More
BIO Releases 5th Annual Emerging Therapeutic Company Trend Report Showing Record Year for Venture Capital Funding

BIO Releases 5th Annual Emerging Therapeutic Company Trend Report Showing Record Year for Venture Capital Funding

Today, the Biotechnology Innovation Organization (BIO) released the 2019 Emerging Therapeutic Company Trend Report, highlighting ten years (2009-2018) of biotechnology funding and deal making across…

Read More
How to navigate the world of startups | Hub

How to navigate the world of startups | Hub

For aspiring entrepreneurs, the thought of building a company from scratch can be daunting. What if no one wants to buy what you're selling?…

Read More
BIO Preview: Some of the Highlights of One of the World’s Premier Life Science Conventions | BioSpace

BIO Preview: Some of the Highlights of One of the World’s Premier Life Science Conventions | BioSpace

The BIO International Convention is being held in Philadelphia from June 3-6, with more than 16,000 attendees expected from around the world. The convention…

Read More